3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Solid Tumors
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Leukemia, Plasma Cell
1
Leukemia, Myeloid, Acute
1
Leukemia, Monocytic, Acute
1
Hodgkin Disease
1
Burkitt Lymphoma
1
Adenocarcinoma, Bronchiolo-Alveolar
1
Adenocarcinoma of Lung
1
Interventions
X-Rays
6
Cyclophosphamide
6
Specimen Handling
5
Phantoms, Imaging
5
Magnetic Resonance Spectroscopy
5
Nuclear Medicine Department, Hospital
4
Biopsy
4
fludarabine
3
Gemcitabine
3
Doxorubicin
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
olaparib
2
mifamurtide
2
larotrectinib
2
ivosidenib
2
fludarabine phosphate
2
ensartinib
2
cabozantinib
2
Methotrexate
2
Mesna
2
Ifosfamide
2
Eflornithine
2
Cisplatin
2
trastuzumab deruxtecan
1
tazemetostat
1
talazoparib
1
selinexor
1
pembrolizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Osteosarcoma
×
pegylated granulocyte colony-stimulating factor
×
30 days
×
Clear all
No trials found.